PharmaBlock Sciences Nanjing Inc Class A (300725) — Cash Flow Quality Index
PharmaBlock Sciences Nanjing Inc Class A (300725) has a Cash Flow Quality Index of 2.04x as of September 2025. Operating cash flow of CN¥83.36 Million exceeds net income of CN¥40.89 Million, indicating high earnings quality where cash backs reported profits. Explore 300725 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PharmaBlock Sciences Nanjing Inc Class A Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for PharmaBlock Sciences Nanjing Inc Class A across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300725 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for PharmaBlock Sciences Nanjing Inc Class A (2013–2024)
Year-by-year earnings quality comparison for PharmaBlock Sciences Nanjing Inc Class A. For live market cap and the full company financial profile, see 300725 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.38x | CN¥302.82 Million | CN¥219.54 Million | ▲ +10.3% |
| 2023 | 1.25x | CN¥246.84 Million | CN¥197.36 Million | ▲ +65.3% |
| 2022 | 0.76x | CN¥246.61 Million | CN¥325.89 Million | ▲ +60.2% |
| 2021 | 0.47x | CN¥238.03 Million | CN¥503.77 Million | ▼ -67.9% |
| 2020 | 1.47x | CN¥271.51 Million | CN¥184.20 Million | ▲ +76.4% |
| 2019 | 0.84x | CN¥127.04 Million | CN¥152.07 Million | ▼ -29.8% |
| 2018 | 1.19x | CN¥160.16 Million | CN¥134.50 Million | ▲ +47.7% |
| 2017 | 0.81x | CN¥54.64 Million | CN¥67.79 Million | ▲ +24.1% |
| 2016 | 0.65x | CN¥22.76 Million | CN¥35.04 Million | ▼ -53.1% |
| 2015 | 1.39x | CN¥27.52 Million | CN¥19.86 Million | ▲ +161.4% |
| 2014 | 0.53x | CN¥11.91 Million | CN¥22.46 Million | ▼ -47.2% |
| 2013 | 1.00x | CN¥18.32 Million | CN¥18.25 Million | — |